PeptideDB

Mianserin HCl (ORG GB-94 HCl) 21535-47-7

Mianserin HCl (ORG GB-94 HCl) 21535-47-7

CAS No.: 21535-47-7

Mianserin HCl (formerly ORG GB-94; ORG-GB 94; Depnon, Lantanon, Lerivon, Lumin, Norval, Tolvon), the hydrochloride salt
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Mianserin HCl (formerly ORG GB-94; ORG-GB 94; Depnon, Lantanon, Lerivon, Lumin, Norval, Tolvon), the hydrochloride salt of mianserin which is a psychoactive tetracyclic compound, is a novel and potent antagonist (inverse agonist) of H1 histamine receptor and 5-HT serotonin receptors used for the treatment of depression. Hematological issues as well as sleepiness could result from it. Though its exact mode of action is unknown, it appears to block certain types of serotonin, histamine H1, and alpha-adrenergic receptors.



Physicochemical Properties


Molecular Formula C18H21CLN2
Molecular Weight 300.83
Exact Mass 300.139
Elemental Analysis C, 71.87; H, 7.04; Cl, 11.78; N, 9.31
CAS # 21535-47-7
Related CAS # Mianserin; 24219-97-4; Mianserin-d3 hydrochloride; 1219804-97-3; 51152-88-6 ((S)-isomer)
PubChem CID 68551
Appearance White to light yellow solid powder
Density 1.18 g/cm3
Boiling Point 411.3ºC at 760 mmHg
Melting Point >230ºC (dec.)
Flash Point 186.1ºC
Vapour Pressure 5.65E-07mmHg at 25°C
LogP 3.888
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 2
Rotatable Bond Count 0
Heavy Atom Count 21
Complexity 342
Defined Atom Stereocenter Count 0
SMILES

CN(CC1)CC2N1C3=CC=CC=C3CC4=CC=CC=C24.Cl

InChi Key YNPFMWCWRVTGKJ-UHFFFAOYSA-N
InChi Code

InChI=1S/C18H20N2.ClH/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19;/h2-9,18H,10-13H2,1H3;1H
Chemical Name

5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene;hydrochloride
Synonyms

ORG GB-94 HCl; Mianserin; Depnon; Lerivon; Lumin; Lantanon; ORG GB-94 HCl; ORG GB 94 HCl; Norval; Tolvon
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets H1 Receptor
ln Vitro

In vitro activity: Mianserin (2 mg/kg s.c.) produces a statistically significant increase in DOPAC levels from a modest baseline to approximately 30% above baseline when compared to saline. Mianserin causes an increase in extracellular norepinephne; however, when compared to desipramine and idazoxan, it was found that the increase in extracellular norepinephne was caused by both NE reuptake inhibition and alpha-2 autoreceptor blockade.[1] Mianserin and eltoprazine exhibit opposing effects in the elevated plus-maze: Eltoprazine exhibits anxiogenic effects whereas menaserin induces anxiolytic effects. Treatment with miranserin causes these sites to become fewer in number, whereas treatment with eltoprazine causes them to become more numerous.[2]

ln Vivo
Mianserin induced regeneration of catecholamine fibers in the rat cerebral cortex. Mianserin has little to no effect on noradrenaline (NA) reuptake, but it may enhance release by blocking presynaptic inhibition mediated by alpha 2-adrenoceptors. In neonatal 6-OHDA-lesioned rats, mianserin attenuates the effects of both m-CPP and SKF 38393, indicating that the actions of DA agonists are mediated by 5-HT neurochemical systems.[4] Mianserin (10 mg/kg, SC) increases extracellular dopamine in the rat's medial prefrontal cortex in a dose-dependent manner up to a factor of approximately six. In the prefrontal cortex, meserin also raises extracellular noradrenaline in a dose-dependent manner.[5]
Animal Protocol
10 mg/kg, SC
Rats
References

[1]. J Pharmacol Exp Ther . 1996 May;277(2):852-60.

[2]. Eur J Pharmacol . 1994 Sep 1;262(1-2):125-31.

[3]. Neuroreport . 1991 Sep;2(9):525-8.

[4]. Psychopharmacology (Berl) . 1995 Jun;119(4):466-73.

[5]. Psychopharmacology (Berl) . 1996 Jan;123(2):127-30.

Additional Infomation A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
See also: Mianserin (annotation moved to).

Solubility Data


Solubility (In Vitro)
DMSO: 50~60 mg/mL (166.2~199.4 mM)
Water: ~30 mg/mL (~99.7 mM)
Ethanol: ~21 mg/mL (~69.8 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (8.31 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (8.31 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (8.31 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.3241 mL 16.6207 mL 33.2414 mL
5 mM 0.6648 mL 3.3241 mL 6.6483 mL
10 mM 0.3324 mL 1.6621 mL 3.3241 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.